Editor's note After the 5G commercial license was officially released, have you imagined how everyone's life would be changed? Imagine in the future, what changes will the new generation of communication technology bring to the medical field? Compared to 4g, 5g technology the 5g technology has a large bandwidth and high rate and the air interface transmission delay is as low as 1 millisecond... So, when the 5g communication technology meets the MGI-based remote ultrasonic diagnostic system MGIU...

SHENZHEN, China and SAN JOSE, Calif., July 2, 2019-- MGI, a subsidiary of BGI Group, expressed confidence in its core patent portfolio in the field of gene sequencing and vowed to fully support the industry to achieve higher quality, more cost-effective sequencing. With leading products and services, MGI has gained support from users in all countries where it has launched, and MGI will fully support industry users to obtain higher quality, more cost-effective sequencing equipment and services. ...

MGISEQ-2000RS High-throughput Sequencing Reagent Kit (SE400) is a new addition to the MGISEQ-2000RS product line of the flagship high-throughput gene sequencer. It is more suitable for long fragment amplicon sequencing, which requires longer single-ended sequencing reads. Field applications, such as short tandem repeats (STR) are widely used in forensic identification with a fragment length of 100-500 bp. The short tandem repeats in the middle result in the inability to use pair-end sequen...

MGI held a “2019 Sequencing Technology and Application Summit” in Beijing June 21-23. More than 200 experts and scholars from domestic and foreign industries in the field of gene sequencing participated in the conference, sharing sequencing technology and applying the latest developments, exploring genetic industry standards and data specifications, building a new ecosystem of industry, and conducting a series of academic exchanges and technical training. At the main forum event on June ...

SHENZHEN, China, June 20, 2019 – MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, and Centre for Translational Microbiome Research (CTMR) at Karolinska Institutet, Stockholm today announced a strategy collaboration in microbiome research and initiated the 10,000 Metagenomics Project as phase one project. The joint-research project is leading by Professor Lars Engstrand and Professor Mathias Uhlén, supporting by Karolinska Institutet and Ferring Pharmaceuticals, using MGI’s DNBSEQTM techno...

The MGISEQ-2000RS FCL sequencing kit features high throughput and low cost per Gb; however, in some situations users don't have enough samples to fill all the lanes, resulting in a much higher run cost. To provide a flexible package, we've developed the MGISEQ-2000RS FCS Sequencing Reagent Kit, which has lower output to make it easier to fully saturate the lanes, while also increasing run speed and flexibility to allow for different combinations of low and medium throughput sequencing. Run more,...